AbCellera Investor Conference Presentation Deck

CORPORATE OVERVIEW COPYRIGHT © ABCELLERA 13 PRE-PARTNERED PROGRAMS: T-CELL ENGAGERS BRING BEST-IN-CLASS T-CELL ENGAGERS TO THE CLINIC, FASTER strike the right balance We have developed hundreds of CD3-binding antibodies that are differentiated from commonly used molecules. ........... build bispecifics We precisely pair parental antibodies with our clinically validated bispecific engineering platform, OrthoMab™ hit tumor targets We streamline discovery of highly specific and developable tumor-binding antibodies for diverse tumor targets. find the right match We identify the optimal pair with high-throughput functional and biophysical assays.

View entire presentation